Cancer Jab Eradicates Tumors in Treatment-Resistant Patients, Trial Shows

A triple-action cancer jab has demonstrated promising results in an international trial, eradicating entire tumors in some patients with head and neck cancer whose disease had become resistant to chemotherapy and immunotherapy. Head and neck cancer is the sixth most common cancer worldwide.